在COVID-19后引入RNA疫苗
1Novartis Pharma GmbH, Nuremberg, Germany.
Methods in molecular biology (Clifton, N.J.)
|May 30, 2024
概括
使者RNA (mRNA) 疫苗为疾病预防和治疗提供了一种灵活有效的方法. 这些RNA疫苗的持续开发有望在疫苗学和免疫治疗中得到更广泛的应用.
科学领域:
- 疫苗学和免疫学 疫苗学和免疫学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 预防性疫苗目前可以预防许多传染病.
- 未来的疫苗学旨在解决新出现的病原体,难治的感染和非传染性疾病.
- RNA疫苗利用基因信息进行抗原表达,比传统的蛋白质抗原具有优势.
研究的目的:
- 审查RNA疫苗技术的关键发展.
- 突出RNA疫苗在疫苗学和免疫治疗中未来应用的潜力.
- 提供关于RNA疫苗的分子生物学方法卷内容的概述.
主要方法:
- 使者RNA-脂质纳米粒子 (mRNA-LNP) 的疫苗技术.
- 利用短暂的遗传信息来进行蛋白质抗原表达.
- 审查现有研究和RNA疫苗开发方面的进展.
主要成果:
- mRNA-LNP疫苗已经证明了临床价值,特别是在COVID-19大流行期间.
- 这些疫苗结合了亚单元和活衰减疫苗的好处,包括灵活的生产和免疫刺激.
- RNA疫苗刺激幽默和细胞免疫,并具有自我辅助的特性.
结论:
- RNA疫苗代表了疫苗学的重大进步.
- 它们的机械多功能性使它们成为未来免疫疗法和疾病预防的关键工具.
- 持续的开发有望实现超越传染病的更广泛应用.
更多相关视频
相关概念视频
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Types of RNA
63.5K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.5K
Vaccinations
44.4K
Overview
44.4K


